Many of the children were also treated with a second (non-artemisinin) drug, lumefantrine. But a high number of kids who got the two-drug combination therapy also saw their illnesses come back, suggesting that the malaria parasite might be developing resistance to lumefantrine, too.

A study conducted in Uganda has found evidence of partial resistance to the primary treatment for malaria in young children with severe forms of the parasitic disease.

Every year around 600,000 people all over the world die from mosquito-borne malaria, among which majority are children under 5.Now, a disturbing news has emerged that the parasite responsible for the Malaria appears to be developing resistance

Scientists have detected resistance to artemisinin, a key malaria drug, for the first time among children in Africa with severe disease. The continent accounts for 95% of all deaths from malaria globally,